All Type of News
Japanese encephalitis vaccine soon to launch in market.
CDjavax, a Japanese encephalitis vaccine has been finally approved for the commercial release since it's conditional registration 5 years ago.
According to Hanyang Security Co., the registration condition was fina...
MOHW eyes further reduction of drug prices
The Ministry of Health and Welfare (MOHW) says it will shortly announced its third measures for ensuring better finance stability in the national health insurance fund, including the revised ex post facto management c...
Civil organizations attack the government's insurance policy including Gleevec
Two civil organizations both for chronic leukemia patients and for promotion of public drugs including Gleevec have recently petitioned the Human Rights Committee, to this effect that the current insurance system, whi...
Dong-A Pharm to file a new drug application for DA-9601
Dong-A Pharm, a drug manufacturer of Gaster (famotidine), has filed a new drug application for its gastric mucosa protective DA-9601 to the Korea Food and Drug Administration on March 15th, after completing its Phase ...
KBRI showing excellent performances in 3 year assessment
Korea Bio-engineering Research Institute (KBRI) established as an independent corporation in May 1999 has been praised as an excellent research performer over years with remarkable progress.
A researcher of the KBR...
Foreign-invested firms to handle returned drugs in dead storage
The Korea Pharmaceutical Association at North Kyungsang province has strongly maintained that foreign-invested firms will actively take part in handing the returned drugs in dead storage, to prevent further aggravatio...
NHI reimbursement for expensive drugs to assess its propriety.
The Health Insurance Review Agency (HIRA) is now going to assess the propriety of the NHI reimbursement for expensive medications as the 2002 Review Project was already approved by the Central Review Commission and th...
Voluntary reduction of insurance-covered drug prices urged
In a recent session with the representatives of the Korea Pharmaceutical Manufacturers Association, Ministry of Health and Welfare Lee Tai-bok has tacitly urged the pharmaceutical firms to voluntarily lower the insura...
Regional biocenters to lure bioventure firms
In a bid to boost the growing concerns on bioindustry in KoREA, some biocenters in every quarter are actively inviting potential bioventure firms to further promote their regional industry development based on more so...
Chosun Pharm determined to shorten the management normalization
A total of 230 employees in Chosun Pharm are struggling to normalize the company management through their in-house campaign to further enhance the productivity and ensure the containment of costs (e.g., double role, m...
